Abstract
Importance of transparency in assessing the feasibility of modeling rare disease.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Medical decision making : an international journal of the Society for Medical Decision Making
Paper Title
Journal
Date